Nexgel, Inc. NXGL
We take great care to ensure that the data presented and summarized in this overview for NEXGEL, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NXGL
View all-
Geode Capital Management, LLC Boston, MA56.8KShares$262,0320.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50KShares$230,3840.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$164,6460.01% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA31.8KShares$146,8190.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.5KShares$131,1770.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA19.3KShares$88,9310.0% of portfolio
-
Tekla Capital Management LLC4.24KShares$19,5600.0% of portfolio
-
Ubs Group Ag2.74KShares$12,6490.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY1.75KShares$8,0810.0% of portfolio
-
Morgan Stanley New York, NY1.6KShares$7,3760.0% of portfolio
Latest Institutional Activity in NXGL
Top Purchases
Top Sells
About NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Insider Transactions at NXGL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 20
2024
|
Nachum Stein Director |
BUY
Open market or private purchase
|
Direct |
3,636
+0.77%
|
$7,272
$2.75 P/Share
|
Nov 20
2024
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
9,090
+5.57%
|
$18,180
$2.75 P/Share
|
Nov 20
2024
|
Adam E Drapczuk Iii Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
17,500
+18.94%
|
$35,000
$2.75 P/Share
|
Nov 20
2024
|
Jerome B Zeldis Director |
BUY
Open market or private purchase
|
Direct |
3,636
+3.3%
|
$7,272
$2.75 P/Share
|
Nov 20
2024
|
Adam R. Levy Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,636
+1.08%
|
$7,272
$2.75 P/Share
|
Nov 20
2024
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
1,818
+1.22%
|
$3,636
$2.75 P/Share
|
Nov 07
2024
|
Nachum Stein Director |
SELL
Bona fide gift
|
Direct |
4,000
-0.85%
|
-
|
Aug 23
2024
|
Nachum Stein Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.08%
|
$20,000
$2.5 P/Share
|
Aug 23
2024
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.45%
|
$20,000
$2.5 P/Share
|
Aug 23
2024
|
Adam E Drapczuk Iii Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+14.84%
|
$20,000
$2.5 P/Share
|
Aug 23
2024
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.42%
|
$20,000
$2.5 P/Share
|
Aug 23
2024
|
Jerome B Zeldis Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.85%
|
$20,000
$2.5 P/Share
|
Mar 01
2024
|
Adam E Drapczuk Iii Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
47,394
+50.0%
|
$94,788
$2.11 P/Share
|
Mar 01
2024
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
11,848
+8.07%
|
$23,696
$2.11 P/Share
|
Mar 01
2024
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
23,697
+14.86%
|
$47,394
$2.11 P/Share
|
Dec 22
2023
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
3,885
+3.06%
|
$7,770
$2.2 P/Share
|
Sep 26
2023
|
Nachum Stein Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.5%
|
$2,500
$1.96 P/Share
|
Sep 14
2023
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
500
+0.44%
|
$1,000
$2.27 P/Share
|
Sep 13
2023
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
6,000
+5.1%
|
$12,000
$2.25 P/Share
|
Sep 12
2023
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
4,000
+3.65%
|
$8,000
$2.28 P/Share
|
Last 12 Months Summary
Open market or private purchase | 176K shares |
---|
Bona fide gift | 4K shares |
---|